Exosomal miR-150 partially attenuated acute lung injury by mediating microvascular endothelial cells and MAPK pathway

Jiaxin Xu1, Dan Xu1, Zhizhong Yu1

  • 1Department of Critical Care Medicine, Union Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan 430022, China.

Bioscience Reports
|November 9, 2021
PubMed
Abstract

Insights

Exosomes carrying microRNA-150 (miRNA-150) show potential in treating acute lung injury (ALI). This study demonstrates that exosomal miRNA-150 reduces inflammation and lung damage by targeting the MAPK pathway.

Area of Science:

  • Biomedical research
  • Stem cell biology
  • Molecular medicine

Background:

  • Acute lung injury (ALI) presents significant morbidity and mortality.
  • Current treatments for ALI are limited, often relying solely on mechanical ventilation.
  • Exosomes and microRNAs (miRNAs) offer promising therapeutic avenues for ALI management.

Purpose of the Study:

  • To investigate the therapeutic potential of exosomes derived from bone marrow stromal stem cells (BMSCs) in a mouse model of ALI.
  • To identify and evaluate the role of specific miRNAs, particularly miR-150, within these exosomes for ALI treatment.

Main Methods:

  • Isolation of exosomes from BMSCs and quantification of miRNA content (miR-542-3p and miR-150).
  • Establishment of an LPS-induced ALI mouse model and treatment with exosomes or miR-150 modulators.
  • Assessment of inflammatory markers, lung edema, tissue damage, apoptosis, and signaling pathways (MAPK).

Main Results:

  • Exosomes derived from BMSCs were successfully isolated and found to be enriched in miR-150.
  • Treatment with exosomes and miR-150 significantly reduced lung inflammation, edema, and preserved alveolar structure.
  • Exosomal miR-150 mitigated microvascular endothelial cell injury by modulating caspase-3, Bax/Bcl-2, and MAPK signaling pathways.

Conclusions:

  • Exosomal miR-150 demonstrates significant therapeutic efficacy in attenuating lipopolysaccharide-induced acute lung injury.
  • The therapeutic effects are mediated through the regulation of the MAPK signaling pathway.
  • This study highlights exosomal miR-150 as a potential novel therapeutic agent for ALI.

Related Concept Videos